Could low-dose aspirin protect against liver cancer?

New research suggests that for adults with chronic viral hepatitis B or C, at high risk of developing liver cancer, long-term, low-dose aspirin use may be associated with reduced risks of disease development and liver-related mortality. Results from a Swedish nationwide registry study, conducted by researchers from the Karolinska Institutet (Solna, Sweden) and Massachusetts General Hospital (MA, USA), suggest that amongst adults at high risk of developing liver cancer, with chronic viral hepatitis B or C, long-term, low-dose aspirin use may be associated with reduced risks of disease development and liver-related mortality. Diagnosis with chronic viral hepatitis, which results from...